Literature DB >> 17579362

A novel deletion in the FTL gene causes hereditary hyperferritinemia cataract syndrome (HHCS) by alteration of the transcription start site.

Kathryn P Burdon1, Shiwani Sharma, Celia S Chen, David P Dimasi, David A Mackey, Jamie E Craig.   

Abstract

Hereditary hyperferritinemia cataract syndrome (HHCS) is characterized by distinctive cataracts and high serum ferritin in the absence of iron overload. It is caused by mutations in the iron response element (IRE) of the Ferritin Light Chain (FTL) gene. Here we investigate the genetics of HHCS in a three generation Australian kindred with typical HHCS ocular lens morphology and high ferritin levels. Initial sequencing of the IRE failed to detect any mutations. Sequencing of the entire gene including the promoter region revealed a novel 25 bp deletion upstream of the IRE abolishing the transcription start site. In lymphoblastoid cells, the deletion allele was transcribed from an alternate start site within the lower stem of the IRE and mutation carriers had high cellular L-ferritin levels. This novel deletion in the promoter encompassing the transcription start site of the FTL gene is responsible for HHCS in this kindred. The initial primers for amplifying the IRE similar to those used by other researchers failed to detect this mutation. Therefore the genomic region assessed in HHCS cases for diagnosis should be expanded to include mutations of this type. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579362     DOI: 10.1002/humu.9501

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

Review 1.  Mammalian iron metabolism and its control by iron regulatory proteins.

Authors:  Cole P Anderson; Macy Shen; Richard S Eisenstein; Elizabeth A Leibold
Journal:  Biochim Biophys Acta       Date:  2012-05-17

2.  Structural effects of linkage disequilibrium on the transcriptome.

Authors:  Joshua S Martin; Matthew Halvorsen; Lauren Davis-Neulander; Justin Ritz; Chetna Gopinath; Arthur Beauregard; Alain Laederach
Journal:  RNA       Date:  2011-11-22       Impact factor: 4.942

3.  Identification and analysis of RNA structural disruptions induced by single nucleotide variants using Riprap and RiboSNitchDB.

Authors:  Jianan Lin; Yang Chen; Yuping Zhang; Zhengqing Ouyang
Journal:  NAR Genom Bioinform       Date:  2020-08-14

4.  Disease-associated mutations that alter the RNA structural ensemble.

Authors:  Matthew Halvorsen; Joshua S Martin; Sam Broadaway; Alain Laederach
Journal:  PLoS Genet       Date:  2010-08-19       Impact factor: 5.917

5.  Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy.

Authors:  Jeremy B Goforth; Sheila A Anderson; Christopher P Nizzi; Richard S Eisenstein
Journal:  RNA       Date:  2009-11-25       Impact factor: 4.942

Review 6.  Hyperferritinaemia-cataract syndrome: worldwide mutations and phenotype of an increasingly diagnosed genetic disorder.

Authors:  Gunda Millonig; Martina U Muckenthaler; Sebastian Mueller
Journal:  Hum Genomics       Date:  2010-04       Impact factor: 4.639

7.  High-Throughput Genetic Screening of 51 Pediatric Cataract Genes Identifies Causative Mutations in Inherited Pediatric Cataract in South Eastern Australia.

Authors:  Shari Javadiyan; Jamie E Craig; Emmanuelle Souzeau; Shiwani Sharma; Karen M Lower; David A Mackey; Sandra E Staffieri; James E Elder; Deepa Taranath; Tania Straga; Joanna Black; John Pater; Theresa Casey; Alex W Hewitt; Kathryn P Burdon
Journal:  G3 (Bethesda)       Date:  2017-10-05       Impact factor: 3.154

8.  Allele-specific SHAPE-MaP assessment of the effects of somatic variation and protein binding on mRNA structure.

Authors:  Lela Lackey; Aaztli Coria; Chanin Woods; Evonne McArthur; Alain Laederach
Journal:  RNA       Date:  2018-01-09       Impact factor: 4.942

9.  A case of iron deficiency anemia with extremely hyperferritinemia responds well to oral iron: the first identified hereditary hyperferritinemia cataract syndrome in China.

Authors:  Mengqi Xu; Xiaosu Zhao; Feng Sun; Rongrong Zhu
Journal:  Ann Hematol       Date:  2020-05-20       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.